CARDIFF ONCOLOGY, INC. Investment Income, Net
CARDIFF ONCOLOGY, INC. (CRDF) reported Investment Income, Net of $57.26 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-10.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2016-03-10
- CARDIFF ONCOLOGY, INC. investment income, net for the quarter ending 2015-12-31 was $24.27K, a 464.62% increase year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, net for the quarter ending 2015-09-30 was $17.37K, a 400.52% increase year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, net for the quarter ending 2015-06-30 was $9.25K, a 344.97% increase year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, net for the quarter ending 2015-03-31 was $6.37K, a 166.37% increase year-over-year.
- CARDIFF ONCOLOGY, INC. investment income, net for fiscal 2015 was $57.26K, a 367.86% increase from fiscal 2014.
- CARDIFF ONCOLOGY, INC. investment income, net for fiscal 2014 was $12.24K, a 234.13% increase from fiscal 2013.
- CARDIFF ONCOLOGY, INC. investment income, net for fiscal 2013 was $3.66K.
- CARDIFF ONCOLOGY, INC. investment income, net for fiscal 2011 was $171.00.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month | Investment Income, Net 152 month | Investment Income, Net 155 month | Investment Income, Net 158 month | Investment Income, Net 161 month | Investment Income, Net 164 month | Investment Income, Net 167 month | Investment Income, Net 170 month | Investment Income, Net 173 month | Investment Income, Net 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $24.27K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $41.64K derived: sum of 2 quarters · filed 2016-03-10 | $50.89K derived: sum of 3 quarters · filed 2016-03-10 | $57.26K 10-K · filed 2016-03-10 | |||||||||
| 2015-09-30 | $17.37K 10-Q · filed 2015-11-09 | $26.62K derived: sum of 2 quarters · filed 2015-11-09 | $32.99K 10-Q · filed 2015-11-09 | $37.29K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2015-06-30 | $9.25K 10-Q · filed 2015-08-10 | $15.62K 10-Q · filed 2015-08-10 | $19.92K derived: sum of 3 quarters · filed 2016-03-10 | $23.39K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2015-03-31 | $6.37K 10-Q · filed 2015-05-05 | $10.67K derived: sum of 2 quarters · filed 2016-03-10 | $14.14K derived: sum of 3 quarters · filed 2016-03-10 | $16.22K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-12-31 | $4.30K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $7.77K derived: sum of 2 quarters · filed 2016-03-10 | $9.85K derived: sum of 3 quarters · filed 2016-03-10 | $12.24K 10-K · filed 2016-03-10 | |||||||||
| 2014-09-30 | $3.47K 10-Q · filed 2015-11-09 | $5.55K derived: sum of 2 quarters · filed 2015-11-09 | $7.94K 10-Q · filed 2015-11-09 | $11.56K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-06-30 | $2.08K 10-Q · filed 2015-08-10 | $4.47K 10-Q · filed 2015-08-10 | $8.09K derived: sum of 3 quarters · filed 2016-03-10 | $8.13K derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-03-31 | $2.39K 10-Q · filed 2015-05-05 | $6.01K derived: sum of 2 quarters · filed 2016-03-10 | $6.05K derived: sum of 3 quarters · filed 2016-03-10 | $272.94K 10-Q · filed 2014-05-12 | |||||||||
| 2013-12-31 | $3.62K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $3.66K derived: sum of 2 quarters · filed 2016-03-10 | $3.66K 10-K · filed 2016-03-10 | $270.55K 10-K · filed 2014-03-17 | |||||||||
| 2013-09-30 | $44.00 10-Q · filed 2014-11-06 | $44.00 10-Q · filed 2014-11-06 | $266.93K 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | $266.88K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $266.88K 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | $266.88K 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | $266.88K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $266.88K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $266.88K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 derived: sum of 3 quarters · filed 2014-03-17 | $171.00 10-K · filed 2014-03-17 | |||||||||
| 2011-09-30 | $3.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $2.00 derived: sum of 2 quarters · filed 2012-11-14 | $173.00 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $170.00 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $171.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |